Fludeoxyglucose F 18
NDC 24562-001, Fludeoxyglucose F-18, injection, solution, from Biomedical Research Foundation of Northwest Louisiana.
- Product NDC
- 24562-001
- Status
- Listed
- Labeler
- Biomedical Research Foundation of Northwest Louisiana
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA203710
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/24562-001 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FLUDEOXYGLUCOSE F-18300 mCi/mL
Pharmacologic classes
Radioactive Diagnostic Agent [EPC]; Radiopharmaceutical Activity [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 24562-001-30 | 24562000130 | 30 mL in 1 VIAL, GLASS (24562-001-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/1deaaa92-1c98-4295-8aa6-7a70bc29f55d
Use it
Look up 24562-001 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/24562-001 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 24562-001. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.